Gene dysregulation by histone variant H2A.Z in bladder cancer

Epigenetics and Chromatin

Volumn 6, Issue 1, 2013, Pages

  Kim, Kyunghwan ^a   Punj, Vasu ^a   Choi, Jongkyu ^a   Heo, Kyu ^a,c   Kim, Jin Man ^a   Laird, Peter W ^b   An, Woojin ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Dongnam Institute of Radiological and Medical Science   (South Korea)

Author keywords

Bladder cancer; ChIP seq; Chromatin; Gene expression; H2A.Z; Histone; Microarray

Indexed keywords

HISTONE H2AZ;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER CELL; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA REPAIR; GENE ACTIVATION; GENE DYSREGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC REGULATION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; NUCLEOSOME; PRIORITY JOURNAL; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

EID: 84885450243     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/1756-8935-6-34     Document Type: Article

References (40)

1. Crystal structure of the nucleosome core particle at 2.8 A resolution. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ, Nature 1997 389 251 260 10.1038/38444 9305837 (Pubitemid 27406632)
2. Histone variants and complexes involved in their exchange. Kusch T, Workman JL, Subcell Biochem 2007 41 91 109 17484125
3. Chromatin modifications and their function. Kouzarides T, Cell 2007 128 693 705 10.1016/j.cell.2007.02.005 17320507 (Pubitemid 46273577)
4. Histone variants-ancient wrap artists of the epigenome. Talbert PB, Henikoff S, Nat Rev Mol Cell Biol 2010 11 264 275 20197778
5. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Wang GG, Allis CD, Chi P, Trends Mol Med 2007 13 373 380 10.1016/j.molmed.2007.07.004 17822959 (Pubitemid 47385382)
6. H2A.Z: view from the top. Zlatanova J, Thakar A, Structure 2008 16 166 179 10.1016/j.str.2007.12.008 18275809 (Pubitemid 351215207)
7. High-resolution profiling of histone methylations in the human genome. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K, Cell 2007 129 823 837 10.1016/j.cell.2007.05.009 17512414 (Pubitemid 46802390)
8. Variant histone H2A.Z is globally localized to the promoters of inactive yeast genes and regulates nucleosome positioning. Guillemette B, Bataille AR, Gevry N, Adam M, Blanchette M, Robert F, Gaudreau L, PLoS Biol 2005 3 384 10.1371/journal.pbio.0030384 16248679 (Pubitemid 41796334)
9. Nucleosome organization in the Drosophila genome. Mavrich TN, Jiang C, Ioshikhes IP, Li X, Venters BJ, Zanton SJ, Tomsho LP, Qi J, Glaser RL, Schuster SC, Gilmour DS, Albert I, Pugh BF, Nature 2008 453 358 362 10.1038/nature06929 18408708 (Pubitemid 351693129)
10. Histone variant H2A.Z marks the 5′ ends of both active and inactive genes in euchromatin. Raisner RM, Hartley PD, Meneghini MD, Bao MZ, Liu CL, Schreiber SL, Rando OJ, Madhani HD, Cell 2005 123 233 248 10.1016/j.cell.2005. 10.002 16239142 (Pubitemid 41457214)
11. The genomic distribution and function of histone variant HTZ-1 during C. elegans embryogenesis. Whittle CM, McClinic KN, Ercan S, Zhang X, Green RD, Kelly WG, Lieb JD, PLoS Genet 2008 4 1000187 10.1371/journal.pgen.1000187 18787694
12. DeltaNp63alpha represses anti-proliferative genes via H2A.Z deposition. Gallant-Behm CL, Ramsey MR, Bensard CL, Nojek I, Tran J, Liu M, Ellisen LW, Espinosa JM, Genes Dev 2012 26 2325 2336 10.1101/gad.198069.112 23019126
13. Gene reactivation by 5-aza-2′-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA, PLoS Genet 2012 8 1002604 10.1371/journal.pgen.1002604 22479200
14. Genome-wide dynamics of Htz1, a histone H2A variant that poises repressed/basal promoters for activation through histone loss. Zhang H, Roberts DN, Cairns BR, Cell 2005 123 219 231 10.1016/j.cell.2005.08.036 16239141 (Pubitemid 41457213)
15. Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S, Nature 2008 456 125 129 10.1038/nature07324 18815594
16. Genome-wide profiling of salt fractions maps physical properties of chromatin. Henikoff S, Henikoff JG, Sakai A, Loeb GB, Ahmad K, Genome Res 2009 19 460 469 19088306
17. Comparative analysis of H2A.Z nucleosome organization in the human and yeast genomes. Tolstorukov MY, Kharchenko PV, Goldman JA, Kingston RE, Park PJ, Genome Res 2009 19 967 977 10.1101/gr.084830.108 19246569
18. Crystal structure of a nucleosome core particle containing the variant histone H2A.Z. Suto RK, Clarkson MJ, Tremethick DJ, Luger K, Nat Struct Biol 2000 7 1121 1124 10.1038/81971 11101893
19. H2A.Z nucleosomes enriched over active genes are homotypic. Weber CM, Henikoff JG, Henikoff S, Nat Struct Mol Biol 2010 17 1500 1507 10.1038/nsmb.1926 21057526
20. Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Conerly ML, Teves SS, Diolaiti D, Ulrich M, Eisenman RN, Henikoff S, Genome Res 2010 20 1383 1390 10.1101/gr.106542.110 20709945
21. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, Shah PK, Liu J, Khramtsov A, Tretiakova MS, Krausz TN, Olopade OI, Rimm DL, White KP, Mol Syst Biol 2008 4 188 18414489
22. H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Svotelis A, Gevry N, Grondin G, Gaudreau L, Cell Cycle 2010 9 364 370 10.4161/cc.9.2.10465 20023423
23. Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Valdes-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, Patterson KI, Tremethick DJ, Stirzaker C, Clark SJ, Genome Res 2012 22 307 321 10.1101/gr.118919.110 21788347
24. EpiChIP: gene-by-gene quantification of epigenetic modification levels. Hebenstreit D, Gu M, Haider S, Turner DJ, Lio P, Teichmann SA, Nucleic Acids Res 2011 39 27 10.1093/nar/gkq1226 21131282
25. Cooperative action of TIP48 and TIP49 in H2A.Z exchange catalyzed by acetylation of nucleosomal H2A. Choi J, Heo K, An W, Nucleic Acids Res 2009 37 5993 6007 10.1093/nar/gkp660 19696079
26. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ, Nature 2006 442 91 95 16728978 (Pubitemid 44064215)
27. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, Burlingame AL, Roeder RG, Brivanlou AH, Allis CD, Cell 2005 121 859 872 10.1016/j.cell.2005.03.036 15960974 (Pubitemid 40806418)
28. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, Wu C, Allis CD, Nature 2006 442 86 90 16728976 (Pubitemid 44064214)
29. p21 transcription is regulated by differential localization of histone H2A.Z. Gevry N, Chan HM, Laflamme L, Livingston DM, Gaudreau L, Genes Dev 2007 21 1869 1881 10.1101/gad.1545707 17671089 (Pubitemid 47204927)
30. A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation. Draker R, Ng MK, Sarcinella E, Ignatchenko V, Kislinger T, Cheung P, PLoS Genet 2012 8 1003047 10.1371/journal.pgen.1003047 23144632
31. H2A.Z sets the stage in ESCs. Pandey R, Dou Y, Cell Stem Cell 2013 12 143 144 10.1016/j.stem.2013.01.012 23395439
32. A histone acetylation switch regulates H2A.Z deposition by the SWR-C remodeling enzyme. Watanabe S, Radman-Livaja M, Rando OJ, Peterson CL, Science 2013 340 195 199 10.1126/science.1229758 23580526
33. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL, Allis CD, Roeder RG, Nat Struct Mol Biol 2006 13 713 719 10.1038/nsmb1128 16878130 (Pubitemid 44175164)
34. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, Wysocka J, Allis CD, Chait BT, Hess JL, Roeder RG, Cell 2005 121 873 885 10.1016/j.cell.2005.04.031 15960975 (Pubitemid 40806419)
35. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W, Mol Cell 1998 2 851 861 10.1016/S1097-2765(00)80299-3 9885572 (Pubitemid 128378992)
36. Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. Kim K, Heo K, Choi J, Jackson S, Kim H, Xiong Y, An W, Mol Cell Biol 2012 32 783 796 10.1128/MCB.06037-11 22184063
37. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Li H, Ruan J, Durbin R, Genome Res 2008 18 1851 1858 10.1101/gr.078212.108 18714091
38. Analysis and simulation of gene expression profiles in pure and mixed cell populations. Hebenstreit D, Teichmann SA, Phys Biol 2011 8 035013 10.1088/1478-3975/8/3/035013 21572174
39. Integrative genomics viewer. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP, Nat Biotechnol 2011 29 24 26 10.1038/nbt.1754 21221095
40. Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1. Heo K, Kim JS, Kim K, Kim H, Choi J, Yang K, An W, Oncogene 2013 32 2510 2520 10.1038/onc.2012.273 22751130